Kidney fibrosis: origins and interventions
T Vanhove, R Goldschmeding, D Kuypers - Transplantation, 2017 - journals.lww.com
All causes of renal allograft injury, when severe and/or sustained, can result in chronic
histological damage of which interstitial fibrosis and tubular atrophy are dominant features …
histological damage of which interstitial fibrosis and tubular atrophy are dominant features …
[HTML][HTML] Protocol biopsies in renal transplantation: prognostic value of structural monitoring
D Seron, F Moreso - Kidney international, 2007 - Elsevier
The natural history of renal allograft damage has been characterized in serial protocol
biopsies. The prevalence of subclinical rejection (SCR) is maximal during the first months …
biopsies. The prevalence of subclinical rejection (SCR) is maximal during the first months …
[HTML][HTML] Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss
F Moreso, M Ibernon, M Goma, M Carrera… - American Journal of …, 2006 - Elsevier
Chronic allograft nephropathy (CAN) in protocol biopsies is associated with graft loss while
the association between subclinical rejection (SCR) and outcome has yielded contradictory …
the association between subclinical rejection (SCR) and outcome has yielded contradictory …
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study
D Rush, D Arlen, A Boucher, S Busque… - American Journal of …, 2007 - Wiley Online Library
We conducted a randomized, multicenter study to determine whether treatment of subclinical
rejection with increased corticosteroids resulted in beneficial outcomes in renal transplant …
rejection with increased corticosteroids resulted in beneficial outcomes in renal transplant …
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts
The contributions of donor kidney quality (partially determined by donor age), allograft
rejection, and calcineurin inhibitor nephrotoxicity on the progression of histologic damage of …
rejection, and calcineurin inhibitor nephrotoxicity on the progression of histologic damage of …
Early subclinical rejection as a risk factor for late chronic humoral rejection
F Moreso, M Carrera, M Goma, M Hueso… - …, 2012 - journals.lww.com
Background. Subclinical rejection and interstitial fibrosis and tubular atrophy (IF/TA) in
protocol biopsies are associated with outcome. We study the relationship between histologic …
protocol biopsies are associated with outcome. We study the relationship between histologic …
Kidney Transplantation With Sirolimus and Mycophenolate Mofetil–Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to …
SM Flechner, D Goldfarb, K Solez, CS Modlin… - …, 2007 - journals.lww.com
Background. We report the 5-year outcomes from a randomized prospective trial in primary
adult renal allograft recipients, designed to evaluate calcineurin inhibitor (CNI)-free …
adult renal allograft recipients, designed to evaluate calcineurin inhibitor (CNI)-free …
[HTML][HTML] Proposed definitions of T cell-mediated rejection and tubulointerstitial inflammation as clinical trial endpoints in kidney transplantation
D Seron, M Rabant, JU Becker… - Transplant …, 2022 - frontierspartnerships.org
The diagnosis of acute T cell-mediated rejection (aTCMR) after kidney transplantation has
considerable relevance for research purposes. Its definition is primarily based on …
considerable relevance for research purposes. Its definition is primarily based on …
Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression
R Danger, L Le Berre, M Cadoux, C Kerleau… - Kidney International, 2023 - Elsevier
We previously established a six-gene–based blood score associated with operational
tolerance in kidney transplantation which was decreased in patients developing anti-HLA …
tolerance in kidney transplantation which was decreased in patients developing anti-HLA …
[HTML][HTML] Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation
Tacrolimus has a narrow therapeutic window and is characterized by a large inter‐individual
variability in bioavailability. The impact of tacrolimus exposure on subclinical evolution of …
variability in bioavailability. The impact of tacrolimus exposure on subclinical evolution of …